Cerebral microbleeds and postthrombolysis intracerebral hemorrhage risk

Neurology

Volumn 85, Issue 11, 2015, Pages 927-934

  Charidimou, Andreas ^a   Shoamanesh, Ashkan ^b   Wilson, Duncan ^a   Gang, Qiang ^a   Fox, Zoe ^c   Jäger, H Rolf ^a   Benavente, Oscar R ^d   Werring, David J ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COHORT ANALYSIS; GROUPS BY AGE; HUMAN; HYPERTENSION; MANTEL HAENSZEL TEST; META ANALYSIS; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; ADVERSE EFFECTS; CEREBRAL HEMORRHAGE; COMPLICATION; FIBRINOLYTIC THERAPY; RISK; STROKE; TREATMENT OUTCOME;

FIBRINOLYTIC AGENT;

CEREBRAL HEMORRHAGE; FIBRINOLYTIC AGENTS; HUMANS; RISK; STROKE; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 84947230094     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001923     Document Type: Article

References (39)

1. Emberson J, Lees KR, Lyden P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-Analysis of individual patient data from randomised trials. Lancet 2014;384:1929-1935.
2. Derex L, Nighoghossian N. Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update. J Neurol Neurosurg Psychiatry 2008;79:1093-1099.
3. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333:1581-1587.
4. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010;9:689-701.
5. Fazekas F, Kleinert R, Roob G, et al. Histopathologic analysis of foci of signal loss on gradient-echo T2-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol 1999;20:637-642.
6. Shoamanesh A, Kwok CS, Benavente O. Cerebral microbleeds: histopathological correlation of neuroimaging. Cerebrovasc Dis 2011;32:528-534.
7. Kidwell CS, Saver JL, Villablanca JP, et al. Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke 2002;33:95-98.
8. Fiehler J, Albers GW, Boulanger JM, et al. Bleeding Risk Analysis in Stroke Imaging Before Thrombolysis (BRASIL): pooled analysis of T2-weighted magnetic resonance imaging data from 570 patients. Stroke 2007;38: 2738-2744.
9. Charidimou A, Kakar P, Fox Z, Werring DJ. Cerebral microbleeds and the risk of intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: systematic review and meta-Analysis. J Neurol Neurosurg Psychiatry 2013; 84:277-280.
10. Shoamanesh A, Kwok CS, Lim PA, Benavente OR. Postthrombolysis intracranial hemorrhage risk of cerebral microbleeds in acute stroke patients: a systematic review and meta-Analysis. Int J Stroke 2013;8:348-356.
11. Charidimou A, Fox Z, Werring DJ. Do cerebral microbleeds increase the risk of intracerebral hemorrhage after thrombolysis for acute ischemic stroke? Int J Stroke 2013; 8:E1-E2.
12. Cordonnier C, Al-Shahi Salman R, Wardlaw J. Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain 2007;130:1988-2003.
13. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-Analyses: the PRISMA statement. BMJ 2009;339:b2535.
14. Stroup DF, Berlin JA, Morton SC, et al. Meta-Analysis of observational studies in epidemiology: a proposal for reporting. Meta-Analysis of Observational Studies in Epidemiology (MOOSE) Group. JAMA 2000;283:2008-2012.
15. Yan SQ, Wan JP, Guo Y, Lou M. Impact of cerebral microbleeds on outcomes of acute ischemic stroke treated with intravenous thrombolysis [in Chinese]. Zhejiang Da Xue Xue Bao Yi Xue Ban 2014;43:20-27.
16. Gratz PP, El-Koussy M, Hsieh K, et al. Preexisting cerebral microbleeds on susceptibility-weighted magnetic resonance imaging and post-Dhrombolysis bleeding risk in 392 patients. Stroke 2014;45:1684-1688.
17. Dannenberg S, Scheitz JF, Rozanski M, et al. Number of cerebral microbleeds and risk of intracerebral hemorrhage after intravenous thrombolysis. Stroke 2014; 45:2900-2905.
18. Moriya Y, Takahashi W, Kijima C, et al. Predictors for hemorrhagic transformation with intravenous tissue plasminogen activator in acute ischemic stroke. Tokai J Exp Clin Med 2013;38:24-27.
19. Kimura K, Aoki J, Shibazaki K, Saji N, Uemura J, Sakamoto Y. New Appearance of extraischemic microbleeds on T2-weighted magnetic resonance imaging 24 hours after tissue-Dype plasminogen activator administration. Stroke 2013;44:2776-2781.
20. Kim HS, Lee DH, Ryu CW, et al. Multiple cerebral microbleeds in hyperacute ischemic stroke: impact on prevalence and severity of early hemorrhagic transformation after thrombolytic treatment. AJR Am J Roentgenol 2006;186:1443-1449.
21. Kakuda W, Thijs VN, Lansberg MG, et al. Clinical importance of microbleeds in patients receiving IV thrombolysis. Neurology 2005;65:1175-1178.
22. Derex L, Nighoghossian N, Hermier M, et al. Thrombolysis for ischemic stroke in patients with old microbleeds on pretreatment MRI. Cerebrovasc Dis 2004;17:238-241.
23. Mazya M, Egido JA, Ford GA, et al. Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: Safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score. Stroke 2012;43:1524-1531.
24. Pantoni L, Fierini F, Poggesi A. Thrombolysis in acute stroke patients with cerebral small vessel disease. Cerebrovasc Dis 2014;37:5-13.
25. van Etten ES, Auriel E, Haley KE, et al. Incidence of symptomatic hemorrhage in patients with lobar microbleeds. Stroke 2014;45:2280-2285.
26. Charidimou A, Kakar P, Fox Z, Werring DJ. Cerebral microbleeds and recurrent stroke risk: systematic review and meta-Analysis of prospective ischemic stroke and transient ischemic attack cohorts. Stroke 2013;44:995-1001.
27. Lovelock CE, Cordonnier C, Naka H, et al. Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage: a systematic review of published and unpublished studies. Stroke 2010;41:1222-1228.
28. Greenberg SM, Eng JA, Ning M, Smith EE, Rosand J. Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke 2004;35:1415-1420.
29. Biffi A, Halpin A, Towfighi A, et al. Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy. Neurology 2010;75:693-698.
30. Wong KS, Chan YL, Liu JY, Gao S, Lam WW. Asymptomatic microbleeds as a risk factor for aspirin-Associated intracerebral hemorrhages. Neurology 2003;60:511-513.
31. Demchuk AM, Khan F, Hill MD, et al. Importance of leukoaraiosis on CT for tissue plasminogen activator decision making: evaluation of the NINDS rt-PA Stroke Study. Cerebrovasc Dis 2008;26:120-125.
32. McCarron MO, Nicoll JA. Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage. Lancet Neurol 2004;3:484-492.
33. Ly JV, Rowe CC, Villemagne VL, et al. Cerebral betaamyloid detected by Pittsburgh compound B positron emission topography predisposes to recombinant tissue plasminogen activator-related hemorrhage. Ann Neurol 2010;68:959-962.
34. Winkler DT, Biedermann L, Tolnay M, et al. Thrombolysis induces cerebral hemorrhage in a mouse model of cerebral amyloid angiopathy. Ann Neurol 2002;51: 790-793.
35. Reuter B, Grudzenski S, Chatzikonstantinou E, et al. Thrombolysis in experimental cerebral amyloid angiopathy and the risk of secondary intracerebral hemorrhage. Stroke 2014;45:2411-2416.
36. Dierksen GA, Skehan ME, Khan MA, et al. Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy. Ann Neurol 2010;68:545-548.
37. Mazya MV, Ahmed N, Ford GA, et al. Remote or extraischemic intracerebral hemorrhage-An uncommon complication of stroke thrombolysis: results from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register. Stroke 2014;45:1657-1663.
38. Ahmed N, Wahlgren N, Grond M, et al. Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR. Lancet Neurol 2010;9:866-874.
39. Charidimou A, Krishnan A, Werring DJ, Rolf Jäger H. Cerebral microbleeds: a guide to detection and clinical relevance in different disease settings. Neuroradiology 2013;55:655-674.